T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Clinical trials for T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New universal CAR t therapy targets tough blood cancers
Disease control Recruiting nowThis early-stage trial tests a new type of immune cell therapy (called universal CAR T cells) for people with certain blood cancers, including T-cell leukemia and lymphoma. The therapy targets a protein called CD7 found on cancer cells. The study will check if the treatment is sa…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Shenzhen Geno-Immune Medical Institute • Aim: Disease control
Last updated Jun 17, 2026 00:15 UTC
-
Engineered donor cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-phase study tests a new treatment for people with T-cell leukemia or lymphoma that has come back. The treatment uses specially trained immune cells from a healthy donor, designed to recognize and attack cancer cells carrying a marker called CD7. The goal is to see if t…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Engineered immune cells take aim at hard-to-treat t-cell cancers
Disease control Recruiting nowThis early-phase trial tests a new treatment for people with T-cell leukemia or lymphoma that has come back or not responded to standard therapy. Doctors take a patient's own T cells, modify them in the lab to recognize and attack cancer cells carrying the CD7 protein, and infuse…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
Supercharged immune cells take aim at tough T-Cell cancers
Disease control Recruiting nowThis early-stage trial tests a new treatment for people with T-cell leukemia or lymphoma that has come back. Doctors take a patient's or donor's immune cells, add a special receptor (anti-CD5 with CD28) to help them recognize and attack cancer cells, then give them back. The main…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: Baylor College of Medicine • Aim: Disease control
Last updated Jun 15, 2026 18:55 UTC
-
New immunotherapy combo aims to control aggressive T-Cell cancers in kids and young adults
Disease control Recruiting nowThis early-phase trial tests whether adding the drug daratumumab after a stem cell transplant can help control high-risk T-cell acute lymphoblastic leukemia or lymphoma in children, adolescents, and young adults. About 30 participants will receive the drug intravenously following…
Matched conditions: T-CELL ACUTE LYMPHOBLASTIC LYMPHOMA
Phase: PHASE1 • Sponsor: New York Medical College • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC